Skip to main content

Peer Review reports

From: REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer

Original Submission
18 Dec 2020 Submitted Original manuscript
21 Apr 2021 Reviewed Reviewer Report
7 May 2021 Reviewed Reviewer Report
20 May 2021 Author responded Author comments - Hiromichi Nakajima
Resubmission - Version 2
20 May 2021 Submitted Manuscript version 2
Publishing
23 May 2021 Editorially accepted
7 Jun 2021 Article published 10.1186/s12885-021-08395-2

You can find further information about peer review here.

Back to article page